Skip to content
Lower risk Medical device recall · FDA · Published December 22, 2020

Fujifilm Wako HDL-C/LDL-C Calibrator Recall: Incorrect Labeling May Cause Wrong Test

Fujifilm recalls Wako HDL-C/LDL-C Calibrator (Lot EL62:9) due to incorrect concentration values on labels, which may lead to inaccurate cholesterol test results. Affected units should be checked for the specific lot number.

🇺🇸 FDA recall #Z-0932-2021Medical deviceFujifilm ›
Take action

Contact the company

Recalling firmFujifilm Medical Systems U.S.A., Inc.81 Hartwell Ave Ste 300 · Lexington, MA 02421-3160
✎ GovInfoNow plain-language explainer

Fujifilm is recalling Wako HDL-C/LDL-C Calibrators from Lot EL629 because the label shows incorrect concentration values. This could cause inaccurate cholesterol test results if used in medical testing. Read more at govinfonow.com/recall/63627-fujifilm-wako-hdl-c-ldl-c-calibrator-recall-incorrect-labeling.

Source Summary by GovInfoNow · govinfonow.com/recall/63627-fujifilm-wako-hdl-c-ldl-c-calibrator-recall-incorrect-labeling · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0932-2021

Cite this page

“Fujifilm Wako HDL-C/LDL-C Calibrator Recall: Incorrect Labeling May Cause Wrong Test.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63627-fujifilm-wako-hdl-c-ldl-c-calibrator-recall-incorrect-labeling. Based on FDA recall #Z-0932-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0932-2021%22&limit=1).

The FDA announced on Dec. 22, 2020, that Fujifilm Medical Systems U.S.A., Inc. is recalling Wako HDL-C/LDL-C Calibrator units due to incorrect concentration values printed on the bottle label for Lot EL629. GovInfoNow's records show this voluntary Class III recall was terminated.

How to tell if you have it

  • Brand: Fujifilm
  • Product: Wako HDL-C/LDL-C Calibrator
  • Lot code: EL629
  • Model number: 990-28011

The hazard

According to the FDA, incorrect concentration values were printed on the bottle label for all product manufactured as part of Lot EL629. This may result in incorrect results when used in testing.

Context

GovInfoNow's records show Fujifilm Medical Systems U.S.A., Inc. has 13 other recalls on record since June 15, 2017. Other recent recalls of similar products include Fujirebio Lumipulse G Amyloid 1-42 Plasma Calibrators Recall (Dec. 11, 2025), Fujirebio Lumipulse Amyloid Plasma Controls Recall (Dec. 11, 2025) and Fujirebio Lumipulse pTau 217 Plasma Controls Recall (Dec. 11, 2025).

How to tell if you have this one

Check the label for the lot number EL629. The product is a Wako HDL-C/LDL-C Calibrator used with Wako L-Type HDL-C or L-Type LDL-C for cholesterol testing.

  • Brand
    Fujifilm
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Label for Lot Number

    Look for the lot number EL629 on the calibrator's label to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 4 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: named in the noticeORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: named in the noticePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “US Nationwide distribution including in the states of MO, OR, MD, PA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Maryland, Missouri, Oregon, Pennsylvania.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Dec 22, 202012. FDA classified it Class III: Jan 28, 202123. Published in FDA’s Enforcement Report: Feb 3, 202134. FDA terminated the recall: Jul 20, 2021420202021
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0932-2021 (December 22, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0932-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA